Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Pan B Cells Monoclonal Antibody (BB6-10A10), FITC

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA528749

Catalog No. PIMA528749


Only null left
Add to Cart

Description

Description

Pan B Cells Monoclonal Antibody for Flow

Pan B Cells antibody specific anti equine reagents have yet to be fully characterized for the typically recognized B-cell makers such as CD19, CD20, CD21, CD22 and CD79. While testing has demonstrated the cross reactivity of some monoclonal B-cell markers raised against other species with equine B cells, such as the Mouse anti Human CD79a antibody, (clone HM57), an overview of which may be found in the report of the second equine leucocyte antigen workshop. Pan B Cells antibody is directed against equine Ig light chains. Characterization studies demonstrated that clone CVS36 bound 100% of CD5-ve peripheral blood lymphocytes and recognized all equine B-cells (Lunn et al. 1998) As the antigen recognized by clone CVS36 appears to be present on the surface of all equine B-cells it is therefore is a reagent that can be used as a pan B-cell marker for domestic horses.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Pan B Cells
Monoclonal
0.5 mg/mL
PBS with <0.1% sodium azide; pH 7.4
Purified
RUO
Pig
Antibody
IgM κ
Flow Cytometry
BB6-10A10
FITC
Mouse
1 mL
Primary
4°C, store in dark
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.